Published by Espicom Business Intelligence, each twice-monthly issue of CNS Drug News keeps you in touch with the companies, products, alliances and research that are shaping global CNS markets, including all degenerative conditions, anxiolytics/sleep disorders, antidepressants, psychotic disorders, anti-epileptics, nausea/vertigo treatments and eating disorders.    

» Visit CNS Drug News
 

Published by Espicom Business Intelligence, The Diabetes Report will keep you fully updated and aid your understanding of the key issues relating to therapies for both Type I and Type II diabetes and their related complications. Every issue features the latest R&D developments, product news and strategic agreements in this high-growth area.
  
» Visit The Diabetes Report


Cardiovascular Drug News is the leading monthly business publication from Espicom Business Intelligence that keeps industry executives in touch with the market for drugs treating all conditions of the heart and circulatory system.
 
» Visit Cardiovascular Drug News 

Published by Espicom Business Intelligence, Autoimmune Drug Focus (ADF) provides a simple, time-saving way for industry executives to keep up-to-date with all the latest developments in this important and high-value pharmaceutical area. 

Regular sections in ADF include diabetes, inflammatory bowel diseases (with features on Crohn's disease and ulcerative colitis), multiple sclerosis, musculoskeletal disorders (with features on rheumatoid arthritis, lupus and more), and psoriasis.

 

» Visit Autoimmune Drug Focus


Piribo is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.  

» Visit Piribo


Thomson Pharma is a comprehensive global pharmaceutical information solution that covers the entire drug discovery and development pipeline. Its competitive intelligence and strategic data can justify and speed your decision-making, facilitate more focused collaboration, and encourage innovation.
  
» Visit Thomson Pharma


Published by NPG, Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.
  
» Visit Bone Marrow Transplantation


Stem cell research offers the hope to cure or alleviate many of today's most devastating diseases, reducing Canada's health care burden, and creating new economic opportunity; however, to secure this future, Canadian researchers must address the pre-clinical issues that are generally too late to be the topic of traditional academic grants but too early for industry sponsorship. The role of the Stem Cell Network (SCN) is to be a catalyst and enabler, addressing this gap with targeted research funding, strong programme management, the engagement of industry and not-for-profit partners, and keen attention to regulatory, ethical, legal and social issues. The Stem Cell Network is a non-profit corporation, established in 2001, that brings together more than 80 leading scientists, clinicians, engineers, and ethicists from universities and hospitals across Canada. Headquartered at the University of Ottawa, the Network is led by Scientific Director Dr. Michael Rudnicki. The Stem Cell Network is one of Canada's Networks of Centres of Excellence (NCE), Canada's flagship science and technology programme. The mission of the Stem Cell Network is to be a catalyst for enabling translation of stem cell research into clinical applications, commercial products and public policy.
  
» Visit Stem Cell Network



StemCells.net is the web portal which aims to keep researchers and business leaders up to date on what’s happening in the dynamic fields of stem cells and regenerative medicine. Updated on a daily basis, the unique mix of exclusive presentations, specialist supplier listings, events, news, scientific posters, conference webcasts and new products makes this a one-stop-shop for essential information.  For reference there are links to research centers, journals, reviews and market reports.
  
» Visit StemCells.net

 

 

The primary objectives of the European Society of Gene and Cell Therapy (ESGCT) are to promote basic and clinical research in gene therapy, cell therapy, and genetic vaccines to promote education and the exchange of information and technology related to above areas and to serve as a professional adviser to the community and to the regulatory bodies in Europe.

 

> Visit the European Society of Gene and Cell Therapy

 

 

Have you read BioWorld Europe’s Special Issue 2007 on ‘Regenerative Medicine & Stem Cells’? Have a look at www.bioworld-europe.com. This magazine provides you with background and in-depth news for creating value. BioWorld Europe, a subscription journal with a targeted circulation of 17,500 across >40 countries in Europe. Enjoy reading … and meet us at Terrapinn’s London Conference.

 

> Visit BioWorld Europe

 

 

 

Bentham Science Publishers, a major STM journal publisher of 79 titles in 2007, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.4) and Current Pharmaceutical Design (Impact Factor 4.8). FREE online journals and information are available.

> Visit Bentham Science
> Visit Current Stem Cell Research & Therapy